ConPath 2.0: hRPE65ミセンスの潜在的病原性を評価するための最適化コンセンサス戦略
Giulio Poli1, Salvatore Galati1, Marco Macchia1
1Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126, Pisa, Italy.
Journal of molecular modeling
|August 20, 2025
まとめ
ヒトのレチノイドイソメラーゼ65 (hRPE65) 変異の影響を迅速に評価するための 計算ツールであるConPath 2.0を開発しました この戦略は,不確実な変種を再分類し,網膜障害に対する遺伝子治療の決定を助けます.
科学分野:
- 遺伝学
- 眼科について
- コンピュータ生物学
背景:
- 人間のレチノイドイソメラーゼ65 (hRPE65) は視覚サイクルに不可欠です.
- hRPE65のMissense変異は, retinitis pigmentosaのような網膜障害と関連しています.
- 多くのhRPE65変種は不確実な重要性 (VUS) を有しており,診断と遺伝子治療の選択を妨げています.
研究 の 目的:
- 不確実な意味を持つhRPE65変異体の病原性を評価するための計算戦略を開発する.
- 200以上のhRPE65VUSを再分類し,遺伝子治療の臨床意思決定を支援する.
主な方法:
- 3Dベースの方法を含む27の予測ツールに拡張することでConPathのアプローチを最適化しました.
- ツール選択のための統計的枠組みを70以上の方法を使って精錬した.
- 既知のhRPE65変種でツール性能を評価し,ClinVarから強化されたConPath 2.0を210VUSに適用しました.
主要な成果:
- 強化された ConPath 2.0 戦略は,hRPE65 VUSの迅速かつ信頼性の高い評価を提供します.
- これらの変数を再分類するために貴重な洞察が生まれました.
- これらの発見は,hRPE65標的遺伝子治療に対する患者の適性を評価するのに臨床医を助けます.
結論:
- ConPath 2.0戦略は,hRPE65 VUSを分類する課題に効果的に取り組んでいます.
- この計算によるアプローチは,網膜障害の正確な診断と個別化された治療戦略を容易にする.
- 遺伝性網膜疾患に対する遺伝子治療の進歩に役立つ.
さらに関連する動画
関連する概念動画
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Point and Frameshift Mutations
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...


